OOIR: Observatory of International Research

Papers

(The H4-Index of World Journal of Gastroenterology is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
Very early onset perinatal constipation: Can it be cow’s milk protein allergy?	406
Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”	398
Molecular mechanisms implicated in SARS-CoV-2 liver tropism	263
Return to work in young and middle-aged colorectal cancer survivors: Factors influencing self-efficacy, fear, resilience, and financial toxicity	221
Endoscopic intramural cystogastrostomy for treatment of peripancreatic fluid collection: A viewpoint from a surgeon	182
Unresolved conundrum of the role of physical activity in irritable bowel disease: What next?	155
Improving early diagnosis of multiple endocrine neoplasia type 1 by assessing the gastrointestinal symptoms, hypercalcemia, and elevated serum gastrin	140
Three-dimensional location approach with silk thread guided hepatectomy for liver tumor	131
Beyond biomarkers: An integrated traditional Chinese medicine-machine learning approach predicts hepatic steatosis in high metabolic risk populations	124
Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease	119
Downregulation of TNFR2 decreases survival gene expression, promotes apoptosis and affects the cell cycle of gastric cancer cells	115
Role of one-step nucleic acid amplification in colorectal cancer lymph node metastases detection	110
Urea breath test for Helicobacter pylori infection in adult dyspeptic patients: A meta-analysis of diagnostic test accuracy	106
Autoimmune liver diseases in systemic rheumatic diseases	91
Machine learning algorithms reveal gut microbiota signatures associated with chronic hepatitis B-related hepatic fibrosis	87
Link between pharyngeal acid reflux episodes and the effectiveness of proton pump inhibitor therapy	87
Systemic treatment for metastatic colorectal cancer	84
Self-management and help-seeking behavior for gastroesophageal reflux symptoms: A population-based survey	81
New objective scoring system to clinically assess fecal incontinence	81
Gastroesophageal reflux after per-oral endoscopic myotomy: Management literature	79
Factors other than fibrosis that increase measured shear wave velocity	76
Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease	73
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The “BE-FIT-IBD” study	73
GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis	72
Involvement of nitrergic neurons in colonic motility in a rat model of ulcerative colitis	72

Gastroesophageal reflux following peroral endoscopic myotomy for achalasia: Bumps in the road to success	70
Artificial intelligence system for the detection of Barrett’s esophagus	69
Contributions of the receptor for advanced glycation end products axis activation in gastric cancer	68
Validation of prognostic scores for predicting acute liver failure and in-hospital death in patients with dengue-induced severe hepatitis	64
Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease	64
Artificial intelligence and inflammatory bowel disease: Where are we going?	64
Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which’s better?	64
Examining dietary interventions in Crohn’s disease	63
Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management	63
Nonlinear association between estimated plasma volume status and acute kidney injury in acute pancreatitis patients	63
Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy	61
Modern drug discovery for inflammatory bowel disease: The role of computational methods	59
Risk factors and a predictive nomogram for lymph node metastasis in superficial esophageal squamous cell carcinoma	59
Carcinoid syndrome caused by a pulmonary carcinoid mimics intestinal manifestations of ulcerative colitis: A case report	59
Diagnostic role of transient elastography in patients with autoimmune liver diseases: A systematic review and meta-analysis	58
MicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma	57
Ethnic genomic differences in esophageal squamous cell carcinoma: Whole-exome sequencing of Han and Kazakh populations in China	55
Endo-hepatology: Bridging the gap between lumen and liver	54
Study of the roles of caspase-3 and nuclear factor kappa B in myenteric neurons in a P2X7 receptor knockout mouse model of ulcerative colitis	53
Perianal fistulizing Crohn’s disease: Mechanisms and treatment options focusing on cellular therapy	53
Exploring the oncogenic potential of SARS-CoV-2 in the gastrointestinal tract	52
Parasites of the liver: A global problem?	51
Targeting Jun N-terminal kinase phosphorylation: A human-derived hepatoprotective peptide human liver transplantation peptide 1 attenuates hepatic ischemia-reperfusion injury	51
Long-term clinical outcomes with filgotinib in ulcerative colitis: 12-month results from the FILGUITO study	50
Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment	49
Development and validation of a nomogram for preoperative prediction of tumor deposits in colorectal cancer	49